Keith Ho is the Director of Strategic Outsourcing and Clinical Innovation at Jazz Pharmaceuticals. He leads and executes the clinical innovation strategy that harnesses digital technologies, data science, and analytics, best practices, and processes to improve the efficiency and quality of clinical trials at Jazz. Prior to Jazz, Keith was a member of Biogen’s Medical Digital and Neurotech Partnership team and was instrumental in developing the vision, strategy, and roadmap for digital biomarker development in neuroscience. He was also responsible for leveraging advanced analytics to gain market, patient, HCP insights. Keith has held past positions in corporate strategy, market research, consulting, and basic research with Merck, Navigant Consulting (now Guidehouse) Bristol-Myers Squibb, Thomas Jefferson University, and holds an MBA from Babson College Olin School of Business, Master of Sciences in Pharmacology from Thomas Jefferson University and Bachelor of Sciences in Biological Sciences from Rowan University.